Study identifies a new biomarker for Alzheimer’s disease in asymptomatic stages

FHS
May 15, 2024
8:23 pm

A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona has identified a new biomarker for Alzheimer’s disease in asymptomatic stages of the disease.

Clarapath and Mayo Clinic Partner to Modernize Pathology Labs

What You Should Know: – Clarapath, a medical robotics company on a mission to transform tissue processing in pathology labs, has announced a strategic collaboration

April 24, 2024

Opinion | Do Your Patients Understand Their Written Discharge Instructions?

Kao is an in-patient hospitalist. As King Charles and Princess of Wales Kate Middleton undergo cancer treatment, no doubt they each have a team of

March 27, 2024

Numinus Wellness Charts Path To Profitability While Strengthening Community Ties | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – May 30, 2024) – Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (“Numinus” or the “Company”), a leader in mental health care and in advancing

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.